SCHEMBL734693

SCHEMBL734693

NC(=O)Cc1c[nH]c2ccccc12.O=S(=O)(NCCc1c[nH]c2ccccc12)c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.80
HDAC3 O15379 1/20 0.61
HDAC4 P56524 1/20 0.61
HDAC1 Q13547 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC2 Q92769 1/20 0.61
HDAC10 Q969S8 1/20 0.61
HDAC11 Q96DB2 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
HDAC9 Q9UKV0 1/20 0.61
HDAC5 Q9UQL6 1/20 0.61
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
KCNA5 P22460 1/20 0.58
KCNH2 Q12809 1/20 0.58
ALDH1A1 P00352 1/20 0.57
GAA P10253 1/20 0.57
MAPT P10636 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30589551 0.89 CYP19A1 (1.00) CYP19A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2945797 0.89 CYP19A1 (1.00) CYP19A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2944086 0.84 CYP19A1 (0.79) CYP19A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL13234493 0.82 CYP19A1 (0.85) CYP19A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5231939 0.82 CYP19A1 (0.81) CYP19A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2951753 0.81 CYP19A1 (0.74) CYP19A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL3262116 0.80 MAPT (0.68) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL40822 0.80 MAPT (0.68) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL29376364 0.80 MAPT (0.68) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL2949291 0.80 CYP19A1 (0.81) CYP19A1MEN1KMT2AKCNA5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 CYP19A1 1385/4885HDAC3 516/4885HDAC4 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.